[Rebroadcast] How does AI assist drug discovery?

This rebroadcast episode of the Labiotech podcast discusses how artificial intelligence (AI) aids in drug discovery. The episode features a conversation with Kyle Tretina from Insilico Medicine, a company that collaborates with the University of Toronto to test AI-designed molecules against “undruggable” cancer targets. The podcast covers various topics including the role of AI in drug development, the concept of “undruggable” targets, and the potentials of quantum computing in drug development.